Member Info for amones

In a single action, the company has added more than 43 million new shares to the existing stock. Shareholders’ losses are of least importance. Shamefully, during the last 2-3 months short positions have reached a peak. Ordinary shareholders can only wonder about the ‘knowledge’ of market makers to guess accurately! What lies ahead, to be sold at an excellent discount?

How long will it take for the market valuation to match the free cash holding in the bank? Good show management!

What are you aiming to buy?

Is this news of fast tracking of cancer vaccines, the reason for the 11% raise in share price observed this morning ? Healthy volume of 8 million and raise of >1 HK$ at HKSE. Good to see.

Watching reported short position numbers. Most recent update from the 13th Feb shows further closure of 2 million short positions compared to the previous week. Overall reduction of nearly 14 million short positions since 3rd Jan. Are “They” better informed than the others?

Nice review LongOdds,

Absolutely correct about Mr Christian Hogg’s role in bringing this company to the limelight in the western corporate world.

The best thing that could be done by the present management is to bring back Mr Hogg to lead the company.

It’s happening at Hong Kong this morning.

Is cash of 1.30 billion attractive enough for any big MNC to look at this? Or else, maket valuation would be lesser than free cash on the books!

In the whole of yesterday’s results, any mention of protecting investors’ interests?

Announcement of results going to be in few hours time and the market is not showing any optimism. Appears, last 3 years of experience has taught a lesson to investors in HK. However, still keeping fingers crossed, expecting a wee bit of good news.

Ok Pencil. Any chance of dividend payment or shares buyback? Lol

Following new drug approvals, collaborations, favourable commercial deals and marketing news, sp and volume go up markedly during Hong Kong trading hours, for few days/weeks at least. Who are those buyers or what is their rationale for buying at ‘peak’ prices? A glance at the sp chart of last few years shows the sp failing to maintain healthy higher levels and invariably falling down again and again. What could be the reason/s behind anyone buying at peak prices (other than 13 being a lucky number!)?

During forthcoming half year results day, will there be any discussion about the market valuation or, the usual scientific presentation of ‘successful achievements’?

PS: latest aggregate short position stands at 33.3 million, three times compared to that of Jan 24 and highest ever, perhaps?

So, it is nothing unusual. Hence, no reason for any excitement with the resolution in the latest AGM. Management has not expressed any concerns about poor performance of shares and about its market valuation. Somehow, short sellers have managed to increase short position to above 30 million. It was under 10 million few months ago. Disappointing.

Regarding repurchasing of shares; was a similar resolution passed in any of the previous AGMs or is it something new?

Jatw, what is your opinion about the alliance news update? Thanks

Lucky number 13.HK has turned out to be a fantastic stock for the short sellers, bringing fortunes after fortunes in the recent past. Looking at today’s numbers at HK, one can assume that few more millions might have been added to the aggregate short numbers. This will not be changing until the company starts sharing the income with its shareholders or starts thinking about its market valuation.

Is it wrong to add ‘any management idea for going private’ to the list of questions prepared by jatw/1pencil?

Takeda being a Japanese pharma, Fruzaqla might not be affected. Just a thought.

I had made a similar enquiry couple years ago. I think jatW had tried answering.

This is nothing to do with HCM.

Imagine a situation where a small company is doing well with manufacturing and marketing and also has enough cash pile. If the market valuation is very low, because of number of other factors, can the management use such a favourable situation to go private? I remember jatW (or, someone else) opining that there would be legal hurdles. Which are such legal hurdles? Would the stock exchange be obliged to query such a move?

Is there a shares related discussion forum for private investors, similar to LSE or Advn, in HK/China? If there is one, we can assume the whinging and questioning to be much harsher and louder.

Pencil, is it really of any use? Year and a half ago, I failed to get any reply or acknowledgment to of my emails. I remember reading here that few other investors have had similar experience. If there are any HK investors following this thread should try to make enquiries . All such investors holding since HK listing or buying at peaks are badly affected. No cash dividends, no mention of buying back shares and in addition, short volumes are going up. Who ever may be the short sellers, one thing is certain; they seem to have great confidence. What could be motivating them to short sell nearly 7 millions of shares while the company is happily announcing a number of achievements during recent weeks?

Reading about the ‘misadventure’ tried at Innovent, makes any long time holders quite nervous. If I were to be an analyst attending Q&A session, I would be asking just one question….

Investors have been expecting for more than a year for the company to provide a similar, simple statement. Not sure, if the management is of the opinion that it is not company’s responsibility to do so. Most of the news/announcements are either about progresses made with R&D, clinical studies or successful collaborations and marketing. If everything else is going well, why is the share price less than half of listing price at HK? Latest figures of declared short positions has touched 22 million, a significant increase compared to last month. Seriously concerned.

Within a day following positive announcement, sp crashes for no reason and short selling increases. What is the reason behind this nonsense? Suspicious to say the least.

Management doesn’t want to pay any dividends. Also not seemed to be concerned about more than 60% decline in share price since HK listing.

Any genuine analyst should be asking couple more questions:

1.How about spending the money in the bank for buying back shares? It might discourage short sellers from pushing the sp further down.

2. Does a low market valuation helping to serve any purpose?